01
Dengue NS1 ELISA Kit
Designed to support the detection of Dengue NS1 antigen and assist healthcare professionals in the early identification of dengue infection.
Future Product Pipeline & Innovation
Driving the Future of Diagnostic Healthcare
Driving the Future of Diagnostic Healthcare
Innovation is a fundamental part of Biolytic Lifesciences Pvt. Ltd.'s long-term vision. Through continuous research, scientific development, and product innovation, we are committed to expanding our diagnostic portfolio and addressing emerging healthcare challenges.
Our Research & Development team actively works on developing advanced diagnostic solutions that improve disease detection, enhance healthcare accessibility, and support better clinical decision-making.
By combining scientific expertise, quality-focused development, and market-driven innovation, Biolytic Lifesciences aims to strengthen its position as a trusted diagnostic solutions provider.
Our Commitment to Innovation
Healthcare challenges continue to evolve, creating a growing need for accurate, affordable, and accessible diagnostic solutions.
At Biolytic Lifesciences, innovation is focused on:
- Developing Next-Generation Diagnostic Technologies
- Expanding Disease Detection Capabilities
- Improving Diagnostic Accessibility
- Supporting Preventive Healthcare
- Enhancing Laboratory Testing Solutions
- Delivering Cost-Effective Diagnostic Products
Our goal is to create products that help healthcare professionals diagnose diseases earlier, manage patients more effectively, and improve healthcare outcomes.
Research & Development Excellence
Research and Development plays a critical role in our growth strategy.
Our R&D activities focus on:
- New Product Development
- Diagnostic Technology Enhancement
- Assay Development
- Product Validation
- Quality Improvement Initiatives
- Healthcare Innovation Programs
Through continuous investment in research, we strive to develop solutions that meet both current and future healthcare needs.
Upcoming ELISA Product Portfolio
Biolytic Lifesciences is actively expanding its ELISA product range to support broader disease detection and diagnostic applications.
Future ELISA Products Include:
02
Dengue IgG ELISA Kit
Developed to support the detection of Dengue IgG antibodies for disease monitoring and diagnostic evaluation.
03
Dengue IgG/IgM ELISA Kit
A comprehensive diagnostic solution intended to assist in the identification of both recent and past dengue infections.
04
Syphilis ELISA Kit
Designed to support laboratory-based screening and diagnostic testing for Syphilis infection.
05
Vitamin D ELISA Kit
Developed to support the quantitative assessment of Vitamin D levels for healthcare and wellness monitoring.
06
Vitamin K ELISA Kit
A diagnostic solution designed to assist in the evaluation of Vitamin K-related healthcare conditions.
Upcoming Rapid Diagnostic Products
Biolytic Lifesciences is also expanding its Rapid Diagnostic portfolio to improve healthcare accessibility and support point-of-care testing.
Future Rapid Diagnostic Products Include:
01
Dengue NS1 Rapid Test Kit
Designed to support rapid screening for Dengue infection.
02
Dengue IgG/IgM Rapid Test Kit
A rapid testing solution for dengue antibody detection.
03
Dengue Combo Rapid Test Kit
A comprehensive dengue screening solution combining multiple detection capabilities.
04
HHH & Syphilis Combo Rapid Test Kit
A multi-parameter diagnostic solution designed to improve screening efficiency.
05
Snake Venom Rapid Test Kit
Developed to assist in the rapid identification of snake venom exposure and support emergency healthcare response.
06
Malaria Pan Rapid Test Kit
Designed for rapid malaria screening and disease detection.
07
Malaria Pan/PF Rapid Test Kit
Supports the identification of multiple malaria variants through rapid diagnostic technology.
08
Malaria PV Rapid Test Kit
Focused on the detection of Plasmodium Vivax malaria infection.
09
Malaria PV/PF Rapid Test Kit
A comprehensive rapid testing solution for malaria screening and identification.
Why Our Pipeline Matters
Our future product pipeline reflects our commitment to healthcare innovation and our dedication to addressing evolving diagnostic needs.
Key Benefits:
- Expanded Disease Detection Capabilities
- Improved Healthcare Accessibility
- Faster Diagnostic Solutions
- Broader Product Availability
- Continuous Healthcare Innovation
- Enhanced Clinical Support
- Better Patient Care Outcomes
Our Vision for the Future
Biolytic Lifesciences envisions becoming a leading diagnostic solutions provider by continuously developing innovative products that support healthcare professionals and improve patient outcomes.
Through scientific excellence, quality-driven development, and continuous innovation, we aim to contribute to a healthier future by making reliable diagnostic solutions more accessible to healthcare communities worldwide.
Innovating Today for a Healthier Tomorrow
Every product in our development pipeline represents our commitment to scientific advancement, healthcare excellence, and better diagnostic outcomes.
As we continue to grow, Biolytic Lifesciences remains dedicated to building the next generation of diagnostic solutions that empower healthcare professionals and improve lives around the world.